submit urlsubmit rss feedadd directoryphysician directoryDirectory of Mobile Health Sites

article

Lyme disease or Lyme borreliosis is the most common vector-borne disease in the Northern Hemisphere. Named after the town of Lyme, Connecticut, it is now one of the fastest growing infectious diseases in the U.S. Lyme disease is caused by infection with the spirochetal bacteria Borrelia burgdorferi, and is primarily transmitted to humans as well as dogs, horses and other domesticated animals by the bite of infected ticks. The causative agent B. burgdorferi was first identified in 1982 by Willy Burgdorfer, a tick-borne disease expert at Rocky Mountain Labs in Hamilton, Montana. The disease varies widely in its presentation, which may include a rash, flu-like symptoms, neurologic, arthritic and/or cardiac manifestations. Early detection and prompt antibiotic treatment usually result in an excellent prognosis, though some patients remain symptomatic. Delayed or inadequate treatment may lead to a chronic illness that is disabling and difficult to treat. Amid great controversy over diagnosis, testing and treatment, two different standards of care for Lyme disease have emerged.

Symptoms


Lyme disease has many signs and symptoms, but skin signs, arthritis and/or various neurological symptoms are often present. Like syphilis, the symptoms frequently seem to resolve, yet the disease progresses. Conventional therapy is with antibiotics. People who suspect they have been exposed to Lyme disease should consult a doctor with knowledge of the disease immediately.

Acute (early) symptoms that may occur

More on [ Lyme disease ]


directory of related categories

 

 
directory of related topics

Vector Borne
Zoonoses
Ticks :: Ticks and Mites

 
Lyme_Disease RSS feed
NEJM — Collection Updates for Infectious Diseases

BOOK REVIEW:
Laboratory medicine has no more urgent role than in the diagnosis and management of infections in immunocompromised patients. For this vulnerable population, clinical algorithms are logically rooted in the need...
ORIGINAL ARTICLE: Evaluation of Universal Antenatal Screening for Group B Streptococcus
Melissa K. Van Dyke, Ph.D., Christina R. Phares, Ph.D., Ruth Lynfield, M.D., Ann R. Thomas, M.D., Kathryn E. Arnold, M.D., Allen S. Craig, M.D., Janet Mohle-Boetani, M.D., Ken Gershman, M.D., William Schaffner, M.D., Susan Petit, M.P.H., Shelley M. Zansky, Ph.D., Craig A. Morin, M.P.H., Nancy L. Spina, M.P.H., Kathryn Wymore, M.P.H., Lee H. Harrison, M.D., Kathleen A. Shutt, M.S., Joseph Bareta, M.P.H., Sandra N. Bulens, M.P.H., Elizabeth R. Zell, M.Stat., Anne Schuchat, M.D., and Stephanie J. Schrag, D.Phil.Background: Group B streptococcal disease is one of the most common infections in the first week after birth. In 2002, national guidelines recommended universal late antenatal screening of pregnant women...
IMAGES IN CLINICAL MEDICINE: Biliary Stones
Ping-Hsien Chen, M.D. and Chiao-Hsiung Chuang, M.D.A 63-year-old woman presented with a 2-day history of fever, abdominal pain, and vomiting. There was no history of previous episodes. Physical examination revealed fever and moderate abdominal tenderness in...

Centers for Disease Control and Prevention

CDC Recommends Shingles Vaccine
People age 60 and older should be vaccinated against shingles, or herpes zoster, a condition often marked by debilitating chronic pain...
New CDC Study Finds Arthritis Can be a Barrier for Adults Seeking to Manage Diabetes through Physical Activity
More than half of adults with diagnosed diabetes also have arthritis, a painful condition that can be a barrier to physical activity—an important health strategy for managing diabetes...
Falls a Leading Cause of Injury-Related Emergency Department Visits for Infants Each Year, CDC Study Shows
Half of the estimated 328,500 infants 12 months of age or younger who were treated for injuries in hospital emergency departments each year from 2001 to 2004 were injured as a result of a fall, according to a study by the Centers for Disease Control and Prevention.

BMC Infectious Diseases - Latest Articles

Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area
Niclas WinqvistPer BjorkmanAnn NorenHakan Miorner Fri, 03 Jul 2009 00:00:00 -0000
Background: In settings with low background prevalence of tuberculosis (TB) infection, interferon-gamma release assays (IGRA) could be useful for diagnosing active TB. This study aims to evaluate the performance of QuantiFERON(R)-TB Gold (QFT-G) in the investigation for suspected active TB, with particular attention to patients originating in high-incidence countries. Furthermore, factors associated with QFT-G results in patients with active TB were assessed. Methods: From patients investigated for clinically suspected active TB, blood was obtained for QFT-G testing, in addition to routine investigations. Positive (PPV) and negative (NPV) predictive values for QFT-G were calculated, comparing patients with confirmed TB and those with other final diagnoses. QFT-G results in TB patients originating from countries with intermediate or high TB incidence were compared with QFT-G results from a control group of recently arrived asymptomatic immigrants from high-incidence countries. Factors associated with QFT-G outcome in patients with confirmed TB were assessed. Results: Among 141 patients, 41/70 (58.6%) with confirmed TB had a positive QFT-G test, compared to 16/71 (22.6%) patients with other final diagnoses, resulting in overall PPV of 71.9% and NPV of 67.6%. For patients with pulmonary disease, PPV and NPV were 61.1% and 67.7%, respectively, and 90.5% and 66.7% for subjects with extrapulmonary manifestations. Comparing patients from high-incidence countries with controls yielded a PPV for active TB of 76.7%, and a NPV of 82.7%. Patients with confirmed TB and positive QFT-G results were characterized by a lower median peripheral white blood cell count (5.9E9/L vs. 8.8E9/L; P<0.001) and a higher median body mass index (22.7 vs. 20.7; P=0.043) as compared to QFT-G-negative TB patients. Conclusions: The overall PPV and NPV of QFT-G for identifying active TB were unsatisfactory, especially for pulmonary disease. Thus, the usefulness of QFT-G for this purpose is questionable. However, a high PPV was observed for extrapulmonary TB and QFT-G might be considered in the diagnostic process in this situation. The PPV and NPV for identifying active TB among persons originating from regions with high-and intermediate TB incidence was similar to that observed in subjects originating in the low-incidence region.
Role of pathogenic oral flora in postoperative pneumonia following brain surgery
Kinga BagyiAngela HaczkuIldiko MartonJudit SzaboAttila GasparMelinda AndrasiImre VargaJudit TothAlmos Klekner Mon, 29 Jun 2009 00:00:00 -0000
Background: Post-operative pulmonary infection often appears to result from aspiration of pathogens colonizing the oral cavity. It was hypothesized that impaired periodontal status and pathogenic oral bacteria significantly contribute to development of aspiration pneumonia following neurosurgical operations. Further, the prophylactic effects of a single dose preoperative cefazolin on the oral bacteria were investigated. Methods: A matched cohort of 18 patients without postoperative lung complications was compared to 5 patients who developed pneumonia within 48 hours after brain surgery. Patients waiting for elective operation of a single brain tumor underwent dental examination and saliva collection before surgery. Bacteria from saliva cultures were isolated and periodontal disease was scored according to type and severity. Patients received 15 mg/kg cefazolin intravenously at the beginning of surgery. Serum, saliva and bronchial secretion were collected promptly after the operation. The minimal inhibitory concentrations of cefazolin regarding the isolated bacteria were determined. The actual antibiotic concentrations in serum, saliva and bronchial secretion were measured by capillary electrophoresis upon completion of surgery. Bacteria were isolated again from the sputum of postoperative pneumonia patients. Results: The number and severity of coexisting periodontal diseases were significantly greater in patients with postoperative pneumonia in comparison to the control group (p=0.031 and p=0.002, respectively). The relative risk of developing postoperative pneumonia in high periodontal score patients was 3.5 greater than in patients who had low periodontal score (p<0.0001). Cefazolin concentration in saliva and bronchial secretion remained below detectable levels in every patient. Conclusions: Presence of multiple periodontal diseases and pathogenic bacteria in the saliva are important predisposing factors of postoperative aspiration pneumonia in patients after brain surgery. The low penetration rate of cefazolin into the saliva indicates that its prophylactic administration may not be sufficient to prevent postoperative aspiration pneumonia. Our study suggests that dental examination may be warranted in order to identify patients at high risk of developing postoperative respiratory infections.
Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.
Ruth MurrayDave BoydMichael MulveyPaul LevettMichelle Alfa Sun, 28 Jun 2009 00:00:00 -0000
Background: The increased severity of disease associated with the NAP1 strain of Clostridium difficile has been attributed to mutations to the tcdC gene which codes for a negative regulator of toxin production. To assess the role of hyper-production of Toxins A and B in clinical isolates of Clostridium difficile, two NAP1-related and five NAP1 non-related strains were compared. Methods: Sequencing was performed on tcdC, tcdR, and tcdE to determine if there were differences that might account for hyper-production of Toxin A and Toxin B in NAP1-related strains. Biological activity of Toxin B was evaluated using the HFF cell CPE assay and Toxin A biological activity was assessed using the Caco-2 Trans-membrane resistance assay. Results: Our results confirm that Toxin A and Toxin B production in NAP1-related strains and ATCC 43255 occurs earlier in the exponential growth phase compared to most NAP1-nonrelated clinical isolates. Despite the hyper-production observed in ATCC 43255 it had no mutations in tcdC, tcdR or tcdE. Analysis of the other clinical isolates indicated that the kinetics and ultimate final concentration of Toxin A and B did not correlate with the presence or lack of alterations in tcdC, tcdR or tcdE. Conclusions: Our data do not support a direct role for alterations in the tcdC gene as a predictor of hyperproduction of Toxin A and B in NAP1-related strains.
Outbreaks of Streptococcus pneumoniae carriage in day care cohorts in Finland - implications for elimination of transmission
Fabian HotiPanu ErastoTuija LeinoKari Auranen Sat, 27 Jun 2009 00:00:00 -0000
Background: Day care centre (DCC) attendees play a central role in maintaining the circulation of Streptococcus pneumoniae (pneumococcus) in the population. Exposure within families and within DCCs are the main risk factors for colonisation with pneumococcal serotypes in DCC attendees. Methods: Transmission of serotype specific carriage was analysed with a continuous time event history model, based on longitudinal data from day care attendees and their family members. Rates of acquisition, conditional on exposure, were estimated in a Bayesian framework utilising latent processes of carriage. To ensure a correct level of exposure, non-participating day care attendees and their family members were included in the analysis. Posterior predictive simulations were used to quantify transmission patterns within day care cohorts, to estimate the basic reproduction number for pneumococcal carriage in a population of day care cohorts, and to assess the critical vaccine efficacy against carriage to eliminate pneumococcal transmission. Results: The model, validated by posterior predictive sampling, was successful in capturing the strong temporal clustering of pneumococcal serotypes in the day care cohorts. In average 2.7 new outbreaks of pneumococcal carriage initiate in a day care cohort each month. While 39% of outbreaks were of size one, the mean outbreak size was 7.6 individuals and the mean length of an outbreak was 2.8 months. The role of families in creating and maintaining transmission was minimal, as only 10% of acquisitions in day care attendees were from family members. Considering a population of day care cohorts, a child-to-child basic reproduction number was estimated as 1.4 and the critical vaccine efficacy against acquisition of carriage as 0.3. Conclusions: Pneumococcal transmission occurs in serotype specific outbreaks of carriage, driven by within-day-care transmission and between-serotype competition. An amplifying effect of the day care cohorts enhances the spread of pneumococcal serotypes within the population. The effect of vaccination, in addition to reducing susceptibility to pneumococcal carriage in the vaccinated, induces a herd effect, thus creating a counter-effect to the amplifying effect of the cohort. Consequently, the critical vaccine efficacy against carriage, required for elimination of transmission, is relatively low. Use of pneumococcal conjugate vaccines is expected to induce a notable herd protection against pneumococcal disease.
Tularemia induces different biochemical responses in BALB/c mice and common voles
Hana BandouchovaJana SedlackovaMiroslav PohankaLadislav NovotnyMartin HubalekFrantisek TremlFrantisek VitulaJiri Pikula Fri, 26 Jun 2009 00:00:00 -0000
Background: Both BALB/c mice and common voles (Microtus arvalis) are considered highly susceptible to tularemia. However, the common vole is reported to harbour Francisella tularensis in European habitats as well as to survive longer with chronic shedding of the bacterium. The purpose of the present study was to compare the response of these two rodents to a wild Francisella tularensis subsp. holarctica strain infection. Methods: Rodents were evaluated for differences in the total antioxidant capacity derived from lowmolecular-weight antioxidants, biochemistry including lipid metabolism, tissue bacterial burdens and histopathology following experimental intraperitoneal infection with 160 colony forming units (CFU) pro toto. Results: Bacterial burdens in common voles started to develop later post-exposure and amounted to lower levels than in BALB/c mice. Elevation of liver function enzymes was more pronounced in mice than common voles and there were marked differences in lipid metabolism in the course of tularemia in these two species. Hypertriglyceridemia and hypercholesterolemia developed in mice, while physiologically higher levels of triglycerides and cholesterol showed a decreasing tendency in common voles. On the other hand, the total plasma antioxidant capacity gradually dropped to 81.5% in mice on day 5 post-infection, while it increased to 130% on day 6 post-infection in common voles. Significant correlations between tissue bacterial burdens and several biochemical parameters were found. Conclusions: As differences in lipid metabolism and the total antioxidant capacity of highly susceptiblerodent species were demonstrated, the role of triglycerides, cholesterol and antioxidants intularemic sepsis should be further investigated.
Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy
Linda EllertsenDag StorlaLien DiepKarl BrokstadHarald WikerGeir Hetland Fri, 26 Jun 2009 00:00:00 -0000
Background: It is still a matter of debate whether there is an association between infection with Mycobacterium tuberculosis (M. tuberculosis) and allergy. Previously, we have shown higher levels of specific IgE to different inhalant allergens and total IgE in tuberculosis (TB) patients compared to controls. The objectives of this study were to evaluate a possible change in allergic sensitisation after successful TB treatment and to confirm the finding of our previous study of enhanced allergic sensitisation in TB patients compared to controls in a more controlled setting. Additionally, we wanted to determine the cytokine profile in the same groups and finally to evaluate the association between Bacillus Calmette-Guerin vaccination (BCG) scar and allergic sensitisation among the controls. Methods: Sera were analysed for specific IgE to inhalant allergens (Phadiatop) and total IgE by the use of ImmunoCAP 1000 (Pharmacia Diagnostics). Thirteen different cytokines were also analysed in the sera by multiplex bead immunoassay (Luminex 100, Luminex Corporation), and clinical symptoms of allergy and BCG scar were reported in a questionnaire. Results: A reduction in levels of specific and total IgE were observed after successful TB treatment. TB patients also had higher levels of specific and total IgE compared to healthy controls. Both interleukin (IL)-6 and interferon (IFN)gamma were higher in tuberculosis patients compared to healthy controls. The levels of IL-6 were reduced after successful tuberculosis treatment. The presence of a BCG scar was associated with a reduced risk of developing allergic sensitisation. Conclusions: We observed a reduced level of allergic sensitisation after successful TB treatment. TB patients seem to be more allergically sensitised than healthy controls confirming our previous finding. Furthermore, we observed an inverse association between allergic sensitisation and visible BCG scar, which adds additional support to the hygiene hypothesis.

 
Subscribe to Infectious_Diseases RSS feed

directory of related sites

Advanced Topics in Lyme Disease - Diagnostic Hints and Treatment Guidelines for Lyme and Other Tick Borne Illnesses, Joseph J. Burrascano, Jr., M.D., 15th Edition, September 2005.

Arthritis Insight: Lyme Disease - Information, including statistics, diagnosis, treatment, community center, news, tips and resources.
Meta Description: [ ArthritisInsight.com is a online guide to arthritis information featuring helpful Chats, message boards, and news to help you deal with the challenges of living with arthritis. ]

CDC: Lyme Disease - The Centers for Disease Control and Prevention presents details of prevention, transmission and symptoms.
Meta Description: [ Information on Lyme Disease. Provided by the U.S. Centers for Disease Control & Prevention. ]

CDC: Lyme Disease - Presents the 1996 Case Definition criteria.
Meta Description: [ Division of Informatics Shared Services ]

Connecticut Tick Control - Fighting Lyme Disease - Comprehensive information regarding tick control and the spread of tick-borne diseases.
Meta Description: [ Connecticut Tick Control offers comprehensive information regarding tick control and the spread of tick-borne diseases. ]

eMedicine Health - Lyme Disease - Consumer health resource center providing information on the causes, symptoms, and treatment of Lyme disease.
Meta Description: [ Lyme disease, sometimes referred to as Lyme infection, is a bacterial illness, transmitted to humans by the bite of deer ticks (Ixodes ticks) carrying a bacterium known as Borrelia burgdorferi. ... ]

Lyme Disease - About.com page with links to news, information, and support for patients with Lyme disease.
Meta Description: [ Lyme disease is a condition with diverse symptoms that can mimic other disorders. Information on the cause, diagnosis, symptoms, prevention, and treatment of Lyme disease. Infectious arthritis can be a secondary consequence of Lyme disease, a disorder caused by a bacterial infection transmitted b... ]

Lyme Disease - A description of Lyme disease along with a look at the symptoms, the later stages, diagnosis, treatment, prevention and what to do if a tick is found on the skin.
Meta Description: [ Information about lyme disease from the American Academy of Family Physicians. ]

404 Lyme Disease - a Monograph and Guide for Washington Physicians - Produced by the Washington State Department of Health, the University of Washington Division of Infectious Diseases and the University of Washington School of Public Health and Community Medicine.
Meta Description: [ Gateway to biomedical and health information from the University of Washington Health Sciences Libraries ]

Lyme Disease Audio Network - The place to hear audio archives of news and public service announcements to help educate people about the seriousness of this disease.
Meta Description: [ The Lyme Disease Audio Network provides the latest information on Lyme disease and other related illnesses in an audio format. ]

Lyme Disease Facts - Factsheet with cause, symptoms, risk factors, diagnosis, complications, treatment, and prevention.

Lyme Disease Info - Covers the symptoms, diagnosis, treatment, and prevention of tick borne infections. Advocacy details, books, and peer-reviewed medical literature are also linked.
Meta Description: [ Lyme Disease Info details the symptoms, diagnosis, treatment and prevention of Lyme disease and other tick borne illnesses. ]

Lyme Disease Information and Support - Located in Boston area Massachusetts. Links and updated information on this and other tick-borne diseases, babesiosis and erlichiosis. Also help getting diagnosed and treated.

Lyme Disease Resource Center - Message boards and chat, newsletter, disease information, patient experiences and stories, directory of related sites, and books for sale.
Meta Description: [ Resources on Lyme Disease, including articles, news, information, message forums and chat rooms, email, books, videos, newsletter, resource directory and more. ]

Lyme Disease Risk Assessments (LDRAs) - Risk assessments conducted by U.S. Army at various military installations, 1983-1996.

Lyme Disease Test Kits: Potential for Misdiagnosis - From the Food and Drug Administration (FDA) Medical Bulletin.

Lyme Disease: A Patient's Guide - Prepared as part of a cooperative agreement between the American College of Physicians and the Centers for Disease Control and Prevention. Includes an introduction, diagnosis, treatment, prevention and a glossary.

Mayo Clinic: Lyme Disease - A description of the disease plus complications, risk factors, diagnosis and treatment.
Meta Description: [ Lyme disease — Comprehensive overview covers symptoms, treatment, complications of this tick-borne illness. ]

Medicinenet.com: Lyme Disease - A definition of this disorder along with a look at the symptoms, diagnoses, treatment and prevention.
Meta Description: [ Learn about the causes, treatments, and how to prevent Lyme disease from tick bites. ]

MedlinePlus: Lyme Disease - The National Institutes of Health provide information on transmission, screening, research, and treatment.
Meta Description: [ Lyme Disease ]

Minnesota Department of Health: Lyme Disease - The State of Minnesota presents general information, information for health care providers, photos, and links to other resources.

Neurological Complications Of Lyme Disease - The National Institute of Neurological Disorders and Stroke offers details of diagnosis and treatment.
Meta Description: [ Neurological Complications of Lyme Disease information page compiled by the National Institue of Neurological Disorders and Stroke (NINDS). ]

New Jersey Department of Health: Lyme Disease and Tickborne Disease - Basic information, and a fact sheet to download.

404 NIAD: Lyme Disease - The National Institute of Allergies and Infectious Diseases presents details of symptoms, treatment and research.
Meta Description: [ Overview of Lyme Disease Research in the Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID) ]

Towards Understanding Lyme Borreliosis in British Columbia - Lyme symptoms and links along with speculation on reservoirs of infection in BC, Canada.

Lyme_Disease related videos
Under Our Skin filmmaker discusses Lyme Disease
Next Video
Lyme_Disease related videos

 

HOMEADVERTISINGABOUT US

articlesartsbusinesscomputersgameshealthhospitalshomekids & teensnewsmobilephysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld


Submit a Site About Become an Editor